Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo-controlled, phase 2 trial - Concepedia

Concepedia

Publication | Open Access

Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo-controlled, phase 2 trial

DOI Full Paper Access

10

Citations

28

References

2018

Year

Jeffrey A. Cohen, Samuel F. Hunter, Theodore R. Brown, Mark Gudesblatt, Ben Thrower, Lily Llorens, Cindy Souza-Prien, April Ruby, David Chernoff, Rajiv Patni

Multiple Sclerosis Journal

Abstract

ADS-5102 was generally well tolerated. These data demonstrate an effect of ADS-5102 on walking speed. Further studies are warranted to confirm these observations.

References

	Year	Citations

Page 1